Induced pluripotent stem cells (iPSCs) as a cellular therapy for post-traumatic osteoarthritis in a murine model

dc.contributor.advisorKrawetz, Roman
dc.contributor.authorCha, Juyeon
dc.contributor.committeememberChu, Li-Fang (Jack)
dc.contributor.committeememberSalo, Paul Timothy
dc.date2025-02
dc.date.accessioned2024-12-19T22:36:31Z
dc.date.available2024-12-19T22:36:31Z
dc.date.issued2024-12-18
dc.description.abstractStem cell therapy holds promise in treating various diseases including the degenerative joint disease known as osteoarthritis (OA). Yet, it is essential to obtain a homogenous cell population in clinically relevant numbers for these therapies. In this study, I scaled-up iPSC culture in suspension bioreactors and then transplanted these cells into the knee joints of mice with OA. I characterized the pluripotency of bioreactor cultured iPSCs using flow cytometry, immunofluorescence, proteomics, and teratoma assay. For in vivo experiments, non-invasive ACL rupture was induced to initiate post-traumatic osteoarthritis (PTOA) in C57BL/6 mice. Post-injury, 5.0x104 iPSCs were intra-articularly injected into the injured knee (N=12), and control animals were injected with DPBS (N=12). To eliminate risk of tumorigenesis, iPSCs expressed the iCaspase9 suicide gene system, which induces apoptosis upon injection of a chemically induced dimerizer (CID). Five days after cell injection, mice were subjected to daily administration of CID for 5 days. Outcomes were measured using histology and gait analysis. Molecular and functional assessment of pluripotency demonstrated that bioreactor grown iPSCs maintained their phenotype during and after the bioprocess. Mice post-ACL rupture treated with iPSCs showed no significant differences in histology compared to the vehicle alone control animals. Gait analysis demonstrated alleviation in gait imbalance after 4 weeks from inducing OA in both iPSC treated and control groups. However, iPSC-treated mice restored gait balance closer to baseline by week 8, compared to control mice. These results demonstrate that iPSCs can be successfully scaled up in bioreactors under controlled conditions and that they offer potential as a therapeutic strategy for PTOA, providing insights for the development of safe and effective iPSC-based cell therapies.
dc.identifier.citationCha, J. (2024). Induced pluripotent stem cells (iPSCs) as a cellular therapy for post-traumatic osteoarthritis in a murine model (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.
dc.identifier.urihttps://hdl.handle.net/1880/120270
dc.language.isoen
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgary
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectInduced pluripotent stem cells (iPSCs)
dc.subjectStem cell therapy
dc.subjectOsteoarthritis (OA)
dc.subject.classificationEngineering--Biomedical
dc.titleInduced pluripotent stem cells (iPSCs) as a cellular therapy for post-traumatic osteoarthritis in a murine model
dc.typemaster thesis
thesis.degree.disciplineEngineering – Biomedical
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameMaster of Science (MSc)
ucalgary.thesis.accesssetbystudentI do not require a thesis withhold – my thesis will have open access and can be viewed and downloaded publicly as soon as possible.
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ucalgary_2024_cha_juyeon.pdf
Size:
2.75 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description: